Horizon Therapeutics plc Makes Founding Gift to Support the

Novel Program Supports Student Education and Future Careers in Patient Advocacy Horizon Therapeutics plc (Nasdaq: HZNP) today announced it has made a founding, five-year gift to establish the University

Related Keywords

Ireland , Tim Walbert , Santiago Schnell , Barbara Calhoun , Matt Flesch , Notre Dame , Rareis Instagram , Ray Gordon , Patient Advocacy Initiative , Instagram , Linkedin , Twitter , Williamk Warren Foundation , College Of Science , Nasdaq , Novel Program Supports Student Education , University Of Notre Dame Patient Advocacy Initiative , Notre Dame College Of Science , Notre Dame Patient Advocacy Initiative , University Of Notre Dame , Boler Parseghian Center , Facebook , Future Careers , Patient Advocacy , Interdisciplinary Minor , Patient Advocacy Summit , Rare Disease Weekend , Horizon Therapeutics , Notre Dame College , Neglected Diseases , Horizon , Herapeutics , Akes , Founding , Gift , Support , University , Otre , Name , Patient , Advocacy , Initiative ,